- Home
- GBX vs AMLX Comparison
GBX vs AMLX Comparison
Compare GBX & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBX
- AMLX
- Stock Information
- Founded
- GBX 1974
- AMLX 2014
- Country
- GBX United States
- AMLX United States
- Employees
- GBX N/A
- AMLX N/A
- Industry
- GBX Railroads
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- GBX Industrials
- AMLX Health Care
- Exchange
- GBX Nasdaq
- AMLX Nasdaq
- Market Cap
- GBX 1.3B
- AMLX 1.3B
- IPO Year
- GBX N/A
- AMLX 2022
- Fundamental
- Price
- GBX $42.62
- AMLX $12.55
- Analyst Decision
- GBX Hold
- AMLX Strong Buy
- Analyst Count
- GBX 2
- AMLX 7
- Target Price
- GBX $57.00
- AMLX $17.43
- AVG Volume (30 Days)
- GBX 389.6K
- AMLX 1.5M
- Earning Date
- GBX 10-28-2025
- AMLX 11-06-2025
- Dividend Yield
- GBX 2.99%
- AMLX N/A
- EPS Growth
- GBX 27.96
- AMLX N/A
- EPS
- GBX 6.35
- AMLX N/A
- Revenue
- GBX $3,240,200,000.00
- AMLX N/A
- Revenue This Year
- GBX N/A
- AMLX N/A
- Revenue Next Year
- GBX N/A
- AMLX N/A
- P/E Ratio
- GBX $6.75
- AMLX N/A
- Revenue Growth
- GBX N/A
- AMLX N/A
- 52 Week Low
- GBX $37.77
- AMLX $2.60
- 52 Week High
- GBX $71.06
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- GBX 42.57
- AMLX 42.87
- Support Level
- GBX $42.00
- AMLX $11.93
- Resistance Level
- GBX $43.67
- AMLX $12.79
- Average True Range (ATR)
- GBX 1.41
- AMLX 0.71
- MACD
- GBX 0.04
- AMLX -0.22
- Stochastic Oscillator
- GBX 56.30
- AMLX 30.92
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.